アステラス製薬 (4503) モデルアップデート: 中計のR&D費計画を織り込み業績予想を修正し、目標株価を2,300円に引き下げ。

Research evidence excerpt

アステラス製薬 (4503) モデルアップデート: 中計のR&D費計画を織り込み業績予想を修正し、目標株価を2,300円に引き下げ。

JP ٜٓ؝٤証券株式会社 ؓةؓقبنؔشؠ 株式調査部

若尾 正示AC 2026 年 6 月 27 日 J P M O R G A N

(81-3) 6736-8612

seiji.wakao@jpmorgan.com

Indonesia: PT J.P. Morgan Sekuritas Indonesia is a member of the Indonesia Stock Exchange and is registered and supervised by the Otoritas Jasa

Keuangan (OJK).

Korea: J.P. Morgan Securities (Far East) Limited, Seoul Branch, is a member of the Korea Exchange (KRX). JPMorgan Chase Bank, N.A., Seoul

Branch, is licensed as a branch office of foreign bank (JPMorgan Chase Bank, N.A.) in Korea. Both entities are regulated by the Financial Services

Commission (FSC) and the Financial Supervisory Service (FSS). For non-macro research material, the material is distributed in Korea by or through

J.P. Morgan Securities (Far East) Limited, Seoul Branch.

Japan: JPMorgan Securities Japan Co., Ltd. and JPMorgan Chase Bank, N.A., Tokyo Branch are regulated by the Financial Services Agency in

Japan.

Malaysia: This material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X), which is a Participating

Organization of Bursa Malaysia Berhad and holds a Capital Markets Services License issued by the Securities Commission in Malaysia.

Mexico: J.P. Morgan Casa de Bolsa, S.A. de C.V., J.P. Morgan Grupo Financiero is member of the Mexican Stock Exchange (˘Bolsa Mexicana de

Valores˙) and the Institutional Stock Exchange (˘Bolsa Institucional de Valores˙), and it is authorized to act as a broker dealer by the National

Banking and Securities Exchange Commission (˘Comisión Nacional Bancaria y de Valores˙).

New Zealand: This material is issued and distributed by JPMSAL in New Zealand only to "wholesale clients" (as defined in the Financial Markets

Conduct Act 2013).